The FDA has announced the recall of one lot of Medtronic MAHURKAR Elite 12 FR x 16cm Acute Dual Lumen Dialysis Catheter with Curved Extensions, IC Trays, product number 8888222316, lot number 1717900160. For details see https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=161871.
The FDA has announced the recall of NxStage PureFlow B Solution Premixed Dialysate for Hemodialysis with NxStage System One because the labeling does not warn that mixing different dialysate solutions on the NxStage System One can be dangerous to a dialysis patient’s health. For details see https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=161806.
The Alaska Kidney Patients Association will present their annual Kidney Education Symposium in Anchorage on April 21, 2018. For more information and to register, see https://www.alaskakidney.org/events/.
In addition to the recently announced April 19, 2018 Job Fair (see https://nwrnbulletins.wordpress.com/2018/03/26/4-19-employment-options-job-fair/), My Employment Options will also present an April 12, 2018 webinar on Job Fair Tips and Tricks. The webinar will cover How to prepare ahead before our April 19th online Fair, How to put yourself in the recruiter’s shoes, Tips on navigating the chat software, Job Fair etiquette tips, What to do after the Job Fair, and other topics. See https://www.myemploymentoptions.com/webinar-registration-page/ for more information and April 12 registration.
The FDA has announced the recall of 598 cases of Fresenius NaturaLyte Liquid Acid Concentrate 2.0 mEq/L, Model # 08-2251-0 3.43 liter bottle, lot 17KTAC076; UDI-00840861101696, because the potassium concentration is not consistent. The Concentrate is used with Fresenius Sodium Bicarb Concentrate in compatible 45X dilution three-stream hemodialysis machines. For details see https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=161727.
The FDA has announced a Class I recall of Becton Dickinson Vacutainer EDTA Blood Collection Tubes with lavender, tan, pink and green rubber tube stoppers due to a chemical in the rubber tube stopper that interferes with the accuracy of testing methodologies. This may cause falsely lower test results from Magellan lead tests, which may lead to improper patient management and treatment for lead exposure or poisoning. For details see https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm602480.htm.
The Tacoma Dialysis Support Group will meet on April 8, 2018, and the second Sunday of every month thereafter. For details see below.